During the past decade, SHI Yaroslavl Regional Clinical Hospital conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 2 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "SHI Yaroslavl Regional Clinical Hospital" are "Rheumatoid Arthritis" (2 trials). Many other conditions were trialed in "SHI Yaroslavl Regional Clinical Hospital" in a lesser frequency.

Most popular intervention types in "SHI Yaroslavl Regional Clinical Hospital" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Adalimumab" (1 trials), "DMARDs (disease-modifying antirheumatic drugs)" (1 trials), "Folic Acid" (1 trials), "GDC-0853" (1 trials) and "MTX" (1 trials). Other intervention names were less common.

The vast majority of trials in "SHI Yaroslavl Regional Clinical Hospital" are 2 trials for "All" genders.

Currently, there are NaN active trials in "SHI Yaroslavl Regional Clinical Hospital". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in SHI Yaroslavl Regional Clinical Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in SHI Yaroslavl Regional Clinical Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".